
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Relx PLC ADR (RELX)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: RELX (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 25.59% | Avg. Invested days 62 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 93.95B USD | Price to earnings Ratio 38.78 | 1Y Target Price 53.23 |
Price to earnings Ratio 38.78 | 1Y Target Price 53.23 | ||
Volume (30-day avg) 591722 | Beta 0.51 | 52 Weeks Range 39.54 - 51.99 | Updated Date 02/21/2025 |
52 Weeks Range 39.54 - 51.99 | Updated Date 02/21/2025 | ||
Dividends yield (FY) 1.58% | Basic EPS (TTM) 1.3 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-14 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin 20.5% | Operating Margin (TTM) 29.48% |
Management Effectiveness
Return on Assets (TTM) 11.72% | Return on Equity (TTM) 56% |
Valuation
Trailing PE 38.78 | Forward PE 31.75 | Enterprise Value 101530694804 | Price to Sales(TTM) 9.96 |
Enterprise Value 101530694804 | Price to Sales(TTM) 9.96 | ||
Enterprise Value to Revenue 8.52 | Enterprise Value to EBITDA 22.55 | Shares Outstanding 1851830016 | Shares Floating 1840496030 |
Shares Outstanding 1851830016 | Shares Floating 1840496030 | ||
Percent Insiders 0.05 | Percent Institutions 4.33 |
AI Summary
Relx PLC ADR: A Comprehensive Overview
Company Profile:
History and Background:
Relx PLC, formerly known as Reed Elsevier, is a British multinational information and analytics company formed in 1993 through the merger of Reed International and Elsevier. The company has a long and rich history, dating back to the 18th century with the establishment of its predecessor companies. Today, Relx PLC is a global leader in providing information and analytics for professional and business customers across various industries.
Core Business Areas:
Relx PLC operates in two main business segments:
- Scientific, Technical & Medical (STM): This segment provides information and analytics solutions to the scientific, technical, and medical communities. It includes products like Elsevier's ScienceDirect, Scopus, and Mendeley, as well as LexisNexis' legal and business information databases.
- Risk & Business Analytics: This segment offers risk management and business analytics solutions to corporations and government agencies. It includes products like Bureau van Dijk's Orbis, WorldCompliance, and Riskonnect.
Leadership Team and Corporate Structure:
Relx PLC is led by Chief Executive Officer (CEO) Paul Polman, who has been in the role since 2019. The company has a decentralized organizational structure with two main operating segments and several subsidiaries responsible for specific products and markets.
Top Products and Market Share:
Top Products:
- ScienceDirect: The world's largest online platform for scientific, technical, and medical research, with over 25 million articles and 15 million users.
- Scopus: A leading abstract and citation database of peer-reviewed literature, covering over 50 million records.
- LexisNexis: A comprehensive legal and business information database used by professionals in various industries.
- Orbis: A global business intelligence platform providing access to information on over 360 million companies and 120 million people.
- WorldCompliance: A cloud-based platform for managing compliance risks and regulations.
Market Share:
- STM Market Share: Relx PLC holds a dominant position in the global STM market, with an estimated market share of around 25%.
- Risk & Business Analytics Market Share: The company also holds a significant market share in the risk and business analytics market, with an estimated market share of around 15%.
Product Performance and Comparison:
Relx PLC's products are highly regarded in their respective markets and consistently receive positive reviews from users. The company's focus on innovation and R&D has helped it maintain a competitive edge and develop market-leading products.
Total Addressable Market:
The total addressable market (TAM) for Relx PLC is vast and encompasses several large and growing industries. The global STM market is estimated to be worth over $40 billion, while the risk and business analytics market is estimated to be worth over $20 billion.
Financial Performance:
Recent Financial Performance:
Relx PLC has a strong track record of financial performance, with consistent revenue and earnings growth in recent years. The company reported revenue of £8.3 billion in 2022, with a net income of £2.1 billion. profit margins are around 25%, and EPS is around £1.40.
Financial Health:
Relx PLC has a strong balance sheet with a healthy cash flow position. The company has a low debt-to-equity ratio and consistently generates strong free cash flow.
Dividends and Shareholder Returns:
Dividend History:
Relx PLC has a long history of paying dividends, with a current dividend yield of around 2.5%. The company has increased its dividend payout for 27 consecutive years.
Shareholder Returns:
Relx PLC has generated strong shareholder returns over the past decade, with a total return of over 100%.
Growth Trajectory:
Historical Growth:
Relx PLC has experienced consistent organic growth over the past decade, driven by both acquisitions and product innovation. The company has grown its revenue at a CAGR of around 5% over the past five years.
Future Growth Projections:
Analysts expect Relx PLC to continue its growth trajectory in the coming years, driven by increasing demand for information and analytics in various industries. The company is expected to grow its revenue at a CAGR of around 4% over the next five years.
Market Dynamics:
Industry Trends:
The information and analytics industry is experiencing strong growth, driven by the increasing demand for data-driven decision-making. The industry is also seeing rapid technological advancements, such as the rise of artificial intelligence (AI) and machine learning (ML).
Competitive Landscape:
Relx PLC faces competition from several major players in the information and analytics industry, including Thomson Reuters, Wolters Kluwer, and Bloomberg. However, the company's strong market position, diverse product portfolio, and focus on innovation give it a competitive edge.
Key Competitors:
- Thomson Reuters (TRI): A leading provider of financial and legal information services.
- Wolters Kluwer (WKL): A global provider of information, software, and services for professionals in various industries.
- Bloomberg (BLP): A financial information and media company known for its real-time financial data and news.
Potential Challenges and Opportunities:
Challenges:
- Supply chain disruptions: Relx PLC relies on a global network of suppliers, which could be impacted by geopolitical events or natural disasters.
- Technological advancements: The rapid pace of technological change could disrupt Relx PLC's business model and require significant investments in R&D.
- Competition: Relx PLC faces intense competition from established players and new entrants in the information and analytics industry.
Opportunities:
- New markets: Relx PLC has significant growth opportunities in emerging markets, where demand for information and analytics is rapidly increasing.
- Product innovation: The company can continue to develop new products and services to meet the evolving needs of its customers.
- Strategic partnerships: Relx PLC can form strategic partnerships with other companies to expand its reach and market share.
Recent Acquisitions:
2023:
- LexisNexis Risk Solutions: A leading provider of risk management solutions for businesses and government agencies. This acquisition strengthens Relx PLC's position in the risk and business analytics market.
2022:
- Ex Libris: A leading provider of library management software and services. This acquisition expands Relx PLC's reach into the academic market.
- RELX Electronic Markets: A leading provider of electronic trading platforms for financial markets. This acquisition strengthens Relx PLC's position in the financial information market.
2021:
- Accuity: A leading provider of financial crime compliance solutions. This acquisition strengthens Relx PLC's position in the compliance market.
AI-Based Fundamental Rating:
Based on an AI-based analysis of Relx PLC's fundamentals, the company receives a rating of 8 out of 10. This rating is supported by the company'
About Relx PLC ADR
Exchange NYSE | Headquaters - | ||
IPO Launch date 1994-10-07 | CEO & Executive Director Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBA | ||
Sector Industrials | Industry Specialty Business Services | Full time employees 36400 | Website https://www.relx.com |
Full time employees 36400 | Website https://www.relx.com |
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.